BioRestorative Therapies (BRTX) Shares Issued (2011 - 2025)
BioRestorative Therapies' (BRTX) quarterly Shares Issued came in at $4.0 million in Q4 2025, up 22.36% YoY from $3.3 million in Q4 2024, and down 24.13% on a QoQ basis from $5.3 million in Q3 2025.
BioRestorative Therapies (BRTX) Shares Issued (2011 - 2025) Analysis & Trends
BioRestorative Therapies (BRTX) has 13 years of Shares Issued data on file, last reported at $4.0 million in Q4 2025.
- Quarterly Shares Issued rose 22.36% year-over-year to $4.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.0 million (up 22.36% YoY) and the FY2025 annual result came in at $4.0 million, up 22.36% from the prior year.
- Shares Issued retreated to $4.0 million in Q4 2025, from $5.3 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $2.4 billion in Q1 2021 to a low of $122117.0 in Q3 2022.
- A 5-year average of $237.1 million and a median of $1.7 million in 2023 frame the typical range for Shares Issued.
- Annual changes were most pronounced in 2021 — Shares Issued jumped 69006.09% — and 2022, when it tumbled 99.96%.
- Tracing BRTX's Shares Issued over 5 years: stood at $839639.0 in 2021, then gained by 2.98% to $864639.0 in 2022, then soared by 69.65% to $1.5 million in 2023, then surged by 122.47% to $3.3 million in 2024, then increased by 22.36% to $4.0 million in 2025.
- The last three Shares Issued figures came in at $4.0 million (Q4 2025), $5.3 million (Q3 2025), and $5.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | BioRestorative Therapies | 1.94 Mn | -1.02 Mn | 17,964.00 | 5.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.99 Mn |
| Dec 31, 2025 | 3.99 Mn |
| Sep 30, 2025 | 5.26 Mn |
| Sep 30, 2025 | 5.26 Mn |
| Jun 30, 2025 | 5.26 Mn |
| Jun 30, 2025 | 5.26 Mn |
| Mar 31, 2025 | 3.44 Mn |
| Mar 31, 2025 | 3.44 Mn |
| Dec 31, 2024 | 3.26 Mn |
| Dec 31, 2024 | 3.26 Mn |
| Sep 30, 2024 | 2.35 Mn |
| Sep 30, 2024 | 2.35 Mn |
| Jun 30, 2024 | 3.40 Mn |
| Jun 30, 2024 | 3.40 Mn |
| Mar 31, 2024 | 2.03 Mn |
| Mar 31, 2024 | 2.03 Mn |
| Dec 31, 2023 | 1.47 Mn |
| Dec 31, 2023 | 1.47 Mn |
| Sep 30, 2023 | 1.12 Mn |
| Sep 30, 2023 | 1.12 Mn |